Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Ischemic Heart Disease

  Free Subscription


1 Am Heart J
5 Am J Emerg Med
2 Angiology
1 Ann Clin Biochem
1 Ann Intern Med
2 Arterioscler Thromb Vasc Biol
1 Can J Cardiol
38 Catheter Cardiovasc Interv
1 Circ J
2 Circulation
1 Clin Cardiol
1 Crit Care Med
1 Dtsch Med Wochenschr
1 Eur Heart J
1 Heart
3 Hypertension
2 Int J Cardiol
3 J Am Coll Cardiol
1 J Mol Cell Cardiol
2 Lancet
5 PLoS One
1 Thromb Haemost

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. CHRISTENSEN DM, Butt JH, Fosbol E, Kober L, et al
    Admission Rates During a Second COVID-19 Lockdown.
    Am Heart J. 2021 Jul 15. pii: S0002-8703(21)00180.
    PubMed         Abstract available

    Am J Emerg Med

  2. SZARPAK L, Jaguszewski MJ, Pruc M, Malysz M, et al
    Safety and efficacy of clopidogrel versus ticagrelor in acute coronary syndrome in the prehospital setting.
    Am J Emerg Med. 2021 Sep 21. pii: S0735-6757(21)00767.

  3. KWAN B, Singh A
    Acute coronary syndrome caused by myocardial bridging.
    Am J Emerg Med. 2021 Sep 6. pii: S0735-6757(21)00720.
    PubMed         Abstract available

  4. YU X
    Potential value of heparin in COVID-19 related cardiovascular disease.
    Am J Emerg Med. 2021 Oct 2. pii: S0735-6757(21)00805.
    PubMed         Abstract available

  5. HESSAMI A, Rezaei N
    Cardiovascular diseases burden in COVID-19.
    Am J Emerg Med. 2021 Oct 2. pii: S0735-6757(21)00803.

  6. LEE E, Ghafoor N, Jefri M, Black AD, et al
    Acute coronary syndrome and transient global amnesia with sumatriptan.
    Am J Emerg Med. 2021 Sep 11. pii: S0735-6757(21)00754.
    PubMed         Abstract available


  7. OZKALAYCI F, Turkyilmaz E, Karagoz A, Karabay CY, et al
    A Clinical Score to Predict "Corrected Thrombolysis in Myocardial Infarction Frame Count" in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Angiology. 2021 Oct 8:33197211045021. doi: 10.1177/00033197211045021.
    PubMed         Abstract available

  8. AKBOGA MK, Inanc IH
    Plasma Leukocyte Cell-Derived Chemotaxin 2 for the Severity of Coronary Artery Disease.
    Angiology. 2021 Oct 11:33197211047326. doi: 10.1177/00033197211047326.

    Ann Clin Biochem

  9. SMITH JD, Leong K, Fazio T, Chiang C, et al
    Troponin least significant change (z-score) is associated with poor clinical outcomes in patients presenting to the emergency department.
    Ann Clin Biochem. 2021;58:297-304.
    PubMed         Abstract available

    Ann Intern Med

  10. BURNS RB, Pignone M, Michos ED, Kanjee Z, et al
    Would You Recommend Aspirin to This Patient for Primary Prevention of Atherosclerotic Cardiovascular Disease? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2021 Oct 12. doi: 10.7326/M21-2596.
    PubMed         Abstract available

    Arterioscler Thromb Vasc Biol

  11. REYES-SOFFER G, Ginsberg HN, Berglund L, Duell PB, et al
    Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Arterioscler Thromb Vasc Biol. 2021 Oct 14:ATV0000000000000147.
    PubMed         Abstract available

  12. BIESSEN EAL, Van Berkel TJC
    N-Acetyl Galactosamine Targeting: Paving the Way for Clinical Application of Nucleotide Medicines in Cardiovascular Diseases.
    Arterioscler Thromb Vasc Biol. 2021 Oct 14:ATVBAHA121316290.
    PubMed         Abstract available


  13. NAGHSHI S, Aune D, Beyene J, Mobarak S, et al
    Dietary intake and biomarkers of alpha linolenic acid and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of cohort studies.
    BMJ. 2021;375:n2213.
    PubMed         Abstract available

    Can J Cardiol

  14. CHEW NWS, Ow ZGW, Teo VXY, Heng RRY, et al
    The Global Effect of the COVID-19 Pandemic on STEMI Care: A Systematic Review and Meta-analysis.
    Can J Cardiol. 2021;37:1450-1459.
    PubMed         Abstract available

    Catheter Cardiovasc Interv

  15. TEHRANI BN, Damluji AA, Sherwood MW, Rosner C, et al
    Transradial access in acute myocardial infarction complicated by cardiogenic shock: Stratified analysis by shock severity.
    Catheter Cardiovasc Interv. 2021;97:1354-1366.
    PubMed         Abstract available

  16. PATEL NJ, Okamoto N, Murphy J, Vengrenyuk Y, et al
    Management of calcified coronary artery bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;97:1407-1416.
    PubMed         Abstract available

  17. ELRAYES MM, Xenogiannis I, Nikolakopoulos I, Vemmou E, et al
    An algorithmic approach to balloon-uncrossable coronary lesions.
    Catheter Cardiovasc Interv. 2021;97:E817-E825.
    PubMed         Abstract available

  18. KALRA S, Doshi D, Sapontis J, Kosmidou I, et al
    Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN-CTO registry.
    Catheter Cardiovasc Interv. 2021;97:1162-1173.
    PubMed         Abstract available

  19. ANDO G, Capodanno D
    Safe femoral access for STEMI patients and mortality in the new decade: Back to the future?
    Catheter Cardiovasc Interv. 2021;97:E1054-E1056.

  20. NIKOLAKOPOULOS I, Vemmou E, Xenogiannis I, Brilakis ES, et al
    Combined use of intravascular lithotripsy and brachytherapy: A new approach for the treatment of recurrent coronary in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97:1402-1406.
    PubMed         Abstract available

  21. YAMAMOTO K, Shiomi H, Morimoto T, Takeji Y, et al
    Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.
    Catheter Cardiovasc Interv. 2020 Oct 16. doi: 10.1002/ccd.29335.
    PubMed         Abstract available

  22. MEDRANDA GA, Lance S, Waksman R, Bernardo NL, et al
    Colossal left main to right atrium fistula ligation complicated by left circumflex STEMI.
    Catheter Cardiovasc Interv. 2021;97:1218-1220.
    PubMed         Abstract available

  23. ALLAHWALA UK, Nour D, Bhatia K, Ward MR, et al
    Prognostic impact of collaterals in patients with a coronary chronic total occlusion: A meta-analysis of over 3,000 patients.
    Catheter Cardiovasc Interv. 2021;97:E771-E777.
    PubMed         Abstract available

  24. PROTTY MB, Gallagher S, Farooq V, Sharp AS, et al
    Combined use of rotational and excimer lASER coronary atherectomy (RASER) during complex coronary angioplasty-An analysis of cases (2006-2016) from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2020 Nov 17. doi: 10.1002/ccd.29377.
    PubMed         Abstract available

  25. WILGENHOF A, Zivelonghi C, Verheye S, Vermeersch P, et al
    Coronary sinus anatomical features: Description and procedural implications during coronary sinus Reducer implantation.
    Catheter Cardiovasc Interv. 2021;97:E929-E935.
    PubMed         Abstract available

  26. DING PYJ, Webber B, Ormiston J, Webster M, et al
    Proximal to distal Y-stenting for coronary bifurcation lesions using radial access: A modern bifurcation technique.
    Catheter Cardiovasc Interv. 2021;97:E951-E955.
    PubMed         Abstract available

  27. WERNER GS, Yaginuma K, Koch M, Tischer K, et al
    Modulated radiation protocol achieves marked reduction of radiation exposure for chronic total coronary occlusion intervention.
    Catheter Cardiovasc Interv. 2021;97:1196-1206.
    PubMed         Abstract available

  28. MEIER D, Fournier S, Masci PG, Eeckhout E, et al
    Impact of manual thrombectomy on microvascular obstruction in STEMI patients.
    Catheter Cardiovasc Interv. 2021;97:1141-1148.
    PubMed         Abstract available

  29. KOLK MZH, van Veelen A, Agostoni P, van Houwelingen GK, et al
    Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion-A subanalysis of the EXPLORE trial.
    Catheter Cardiovasc Interv. 2021;97:1176-1183.
    PubMed         Abstract available

  30. GARCIA S, Schmidt CW, Garberich R, Henry TD, et al
    Temporal changes in patient characteristics and outcomes in ST-segment elevation myocardial infarction 2003-2018.
    Catheter Cardiovasc Interv. 2021;97:1109-1117.
    PubMed         Abstract available

  31. PATTERSON C, Sapontis J, Nicholson WJ, Lombardi W, et al
    Impact of body mass index on outcome and health status after chronic total occlusion percutaneous coronary intervention: Insights from the OPEN-CTO study.
    Catheter Cardiovasc Interv. 2021;97:1186-1193.
    PubMed         Abstract available

  32. KARAMASIS GV, Kalogeropoulos AS, Gamma RA, Clesham GJ, et al
    Effects of stent postdilatation during primary PCI for STEMI: Insights from coronary physiology and optical coherence tomography.
    Catheter Cardiovasc Interv. 2021;97:1309-1317.
    PubMed         Abstract available

  33. KURIHARA O, Shinohara H, Kim HO, Russo M, et al
    Comparison of post-stent optical coherence tomography findings: Layered versus non-layered culprit lesions.
    Catheter Cardiovasc Interv. 2021;97:1320-1328.
    PubMed         Abstract available

  34. PAHUJA M, Ranka S, Chehab O, Mishra T, et al
    Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock.
    Catheter Cardiovasc Interv. 2021;97:1129-1138.
    PubMed         Abstract available

  35. AZZALINI L, Baber U, Johal GS, Farhan S, et al
    One-year outcomes of patients undergoing complex percutaneous coronary intervention with three contemporary drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;97:1341-1351.
    PubMed         Abstract available

  36. KIM MC, Bae S, Ahn Y, Sim DS, et al
    Benefit of a staged in-hospital revascularization strategy in hemodynamically stable patients with ST-segment elevation myocardial infarction and multivessel disease: Analyses by risk stratification.
    Catheter Cardiovasc Interv. 2021;97:1151-1159.
    PubMed         Abstract available

  37. VOGT JC, Manning PG, Sheikh O, Aronow HD, et al
    The role of rivaroxaban for patients with atherosclerotic vascular disease in the modern era.
    Catheter Cardiovasc Interv. 2021;97:1221-1229.

  38. CHEN S, David SW, Khan ZA, Metzger DC, et al
    One-year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC-HOT study.
    Catheter Cardiovasc Interv. 2021;97:1120-1126.
    PubMed         Abstract available

  39. LI X, Kan J, She L, Shrestha R, et al
    Optical coherence tomography predictors of target vessel myocardial infarction after provisional stenting in patients with coronary bifurcation disease.
    Catheter Cardiovasc Interv. 2021;97:1331-1340.
    PubMed         Abstract available

  40. AHSAN MJ, Lateef N, Latif A, Malik SU, et al
    A systematic review and meta-analysis of impact of baseline thrombocytopenia on cardiovascular outcomes and mortality in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Nov 24. doi: 10.1002/ccd.29405.
    PubMed         Abstract available

  41. LABIN JE, Saggar R, Yang EH, Lluri G, et al
    Left main coronary artery compression in pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29401.
    PubMed         Abstract available

  42. KARROWNI W, Zaeiter H, Mansour S, Nassar P, et al
    Tip fracture of the crown of orbital atherectomy device in angulated left circumflex lesion.
    Catheter Cardiovasc Interv. 2021;97:1399-1401.
    PubMed         Abstract available

  43. KERN MJ, Seto AH
    Post-dilation in ST-elevation MI patients makes sense anatomically, but does it improve physiology?
    Catheter Cardiovasc Interv. 2021;97:1318-1319.

  44. BELARDI JA, Lamelas PM
    Contemporary stents: Tough to get better.
    Catheter Cardiovasc Interv. 2021;97:1352-1353.

  45. TOPAZ O
    The inconsistency of manual thrombectomy and the role of contemporary thrombus grading in PCI for STEMI.
    Catheter Cardiovasc Interv. 2021;97:1149-1150.

  46. GUDDETI RR, Brilakis ES
    With great power comes great responsibility: When and how to use the retrograde approach to chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2021;97:1174-1175.

  47. NAGARAJA V, Rao SV, George S, Mamas M, et al
    Evidence-based arterial access site practice in patients with acute coronary syndromes: Has SAFARI-STEMI changed the landscape?
    Catheter Cardiovasc Interv. 2021;97:1417-1421.

  48. SHADMAN S, Heyliger S, Watts C, Aghili N, et al
    Successful impella-assisted suction thrombectomy of right heart thrombus via the AngioVac device: Advantages, limitations, and alternatives.
    Catheter Cardiovasc Interv. 2021;97:1296-1300.
    PubMed         Abstract available

  49. BRUNO F, De Filippo O, Conrotto F, D'Ascenzo F, et al
    Response to: Angiography versus FFR-guided coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021 Feb 7. doi: 10.1002/ccd.29542.

  50. ADUSUMALLI S, Dautov R
    An ultra-low-profile 0.85 mm Nano Hydro balloon to treat wire-crossable balloon-uncrossable lesions: A useful tool in CTO armamentarium.
    Catheter Cardiovasc Interv. 2021;97:1213-1217.
    PubMed         Abstract available

  51. LEMOR A, Al-Darzi W, O'Neill W, Basir MB, et al
    Unmasking right ventricular failure in cardiogenic shock: The importance of serial hemodynamics.
    Catheter Cardiovasc Interv. 2021;97:1209-1212.
    PubMed         Abstract available

  52. SCOTTI A, Godino C, Munafo A, Pivato CA, et al
    Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel.
    Catheter Cardiovasc Interv. 2020 Dec 17. doi: 10.1002/ccd.29425.
    PubMed         Abstract available

    Circ J

  53. NISHIHIRA K, Shibata Y
    Achieving Better Risk Prediction and Outcome in Japanese Patients With Acute Myocardial Infarction.
    Circ J. 2021 Oct 14. doi: 10.1253/circj.CJ-21-0797.


  54. JACOBS AK, Ali MJ, Best PJ, Bieniarz MC, et al
    Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart Association.
    Circulation. 2021 Oct 13:CIR0000000000001025. doi: 10.1161/CIR.0000000000001025.
    PubMed         Abstract available

  55. LEE LY, Oldham WM, He H, Wang R, et al
    Interferon-gamma Impairs Human Coronary Artery Endothelial Glucose Metabolism via Tryptophan Catabolism and Activates Fatty Acid Oxidation.
    Circulation. 2021 Oct 12. doi: 10.1161/CIRCULATIONAHA.121.053960.
    PubMed         Abstract available

    Clin Cardiol

  56. NARANG N, Dela Cruz M, Imamura T, Chung B, et al
    Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure.
    Clin Cardiol. 2021 Mar 18. doi: 10.1002/clc.23584.
    PubMed         Abstract available

    Crit Care Med

  57. SPOORMANS EM, Lemkes JS, Janssens GN, van der Hoeven NW, et al
    Targeted Temperature Management in Out-of-Hospital Cardiac Arrest With Shockable Rhythm: A Post Hoc Analysis of the Coronary Angiography After Cardiac Arrest Trial.
    Crit Care Med. 2021 Sep 22. pii: 00003246-900000000-95084.
    PubMed         Abstract available

    Dtsch Med Wochenschr

  58. GASSANOV N, Eicke M, Er F
    [Aspirin in primary prevention of cardiovascular and cerebrovascular diseases].
    Dtsch Med Wochenschr. 2021;146:1353-1359.
    PubMed         Abstract available

    Eur Heart J

  59. LECHNER I, Reindl M, Tiller C, Holzknecht M, et al
    Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a cardiac magnetic resonance imaging study.
    Eur Heart J. 2021 Oct 11. pii: 6386704. doi: 10.1093.
    PubMed         Abstract available


  60. DE ABAJO FJ, Rodriguez-Martin S, Barreira D, Rodriguez-Miguel A, et al
    Influenza vaccine and risk of acute myocardial infarction in a population-based case-control study.
    Heart. 2021 Oct 13. pii: heartjnl-2021-319754. doi: 10.1136/heartjnl-2021-319754
    PubMed         Abstract available


  61. CERDEIRA AS, Rana S, Karumanchi SA
    Is Prolonging Gestation in Preeclampsia For Better or Worse in Preventing Cardiovascular Disease?
    Hypertension. 2021;78:1395-1397.

  62. BORGHI C, Piani F
    Uric Acid and Risk of Cardiovascular Disease: A Question of Start and Finish.
    Hypertension. 2021;78:1219-1221.

  63. SCHUTTE AE, Gnanenthiran SR
    Toward a Better Understanding of Why Cumulative Blood Pressure Is Such a Strong Predictor of Cardiovascular Outcomes.
    Hypertension. 2021;78:1267-1269.

    Int J Cardiol

  64. CHIANG CH, Chiang CH, Chiang CH
    Is single troponin measurement truly safe enough to rule out myocardial infarction in early presenters?
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01388.

  65. CHALIKIAS G, Tziakas DN
    Triggering receptor expressing on myeloid cells (TREM)-1 and acute myocardial infarction: An association vs. causality conundrum.
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01507.

    J Am Coll Cardiol

  66. MORLEY-SMITH A, Quinn D, Lim HS
    Temporary Mechanical Circulatory Support: An Intervention in Need of a Strategy.
    J Am Coll Cardiol. 2021;77:1954.

  67. CAVALLARI I, Bhatt DL, Steg PG, Leiter LA, et al
    Causes and Risk Factors for Death in Diabetes: A Competing-Risk Analysis From the SAVOR-TIMI 53 Trial.
    J Am Coll Cardiol. 2021;77:1837-1840.

  68. TRUDEL X, Brisson C, Talbot D, Gilbert-Ouimet M, et al
    Long Working Hours and Risk of Recurrent Coronary Events.
    J Am Coll Cardiol. 2021;77:1616-1625.
    PubMed         Abstract available

    J Mol Cell Cardiol

  69. JEZEK F, Randall EB, Carlson BE, Beard DA, et al
    Systems analysis of the mechanisms governing the cardiovascular response to changes in posture and in peripheral demand during exercise.
    J Mol Cell Cardiol. 2021 Oct 6. pii: S0022-2828(21)00191.
    PubMed         Abstract available


  70. TSAMPASIAN V, Maart C, Vassiliou VS, Garg P, et al
    Mitral valve disease in sarcoidosis diagnosed by cardiovascular magnetic resonance.
    Lancet. 2021;398:1358.

  71. KIM CJ, Park MW, Kim MC, Choo EH, et al
    Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised tr
    Lancet. 2021;398:1305-1316.
    PubMed         Abstract available

    PLoS One

  72. ZHENG X, Li J, Yue P, Liu L, et al
    Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis.
    PLoS One. 2021;16:e0248812.
    PubMed         Abstract available

  73. BOUCHE L, Kamel R, Tamareille S, Garcia G, et al
    DRP1 haploinsufficiency attenuates cardiac ischemia/reperfusion injuries.
    PLoS One. 2021;16:e0248554.
    PubMed         Abstract available

  74. SIEPMANN R, Nilius H, Mueller F, Mueller K, et al
    Image-derived mean velocity measurement for prediction of coronary flow reserve in a canonical stenosis phantom using magnetic particle imaging.
    PLoS One. 2021;16:e0249697.
    PubMed         Abstract available

  75. ROSSI C, Berta P, Curello S, Lovaglio PG, et al
    The impact of COVID-19 pandemic on AMI and stroke mortality in Lombardy: Evidence from the epicenter of the pandemic.
    PLoS One. 2021;16:e0257910.
    PubMed         Abstract available

  76. GRUZDEVA OV, Belik EV, Dyleva YA, Borodkina DA, et al
    Expression of adipocytokines in heart fat depots depending on the degree of coronary artery atherosclerosis in patients with coronary artery disease.
    PLoS One. 2021;16:e0248716.
    PubMed         Abstract available

    Thromb Haemost

  77. CALDERONE D, Greco A, Ingala S, Agnello F, et al
    Efficacy and safety of aspirin for cardiovascular risk prevention in younger and older age: an updated systematic review and meta-analysis.
    Thromb Haemost. 2021 Oct 12. doi: 10.1055/a-1667-7427.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.